Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,673
Total Claims
$658K
Drug Cost
547
Beneficiaries
$1,202
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-15%
Cost per patient vs peers
$1,202 vs $1,411 avg
-13%
Brand preference vs peers
9.2% vs 10.6% avg
Brand vs Generic
Brand: 1,053 claims · $489K
Generic: 10,386 claims · $163K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 158 | $91K |
| Sitagliptin Phosphate | 92 | $68K |
| Rivaroxaban | 92 | $56K |
| Dapagliflozin Propanediol | 69 | $41K |
| Insulin Glargine,hum.Rec.Anlog | 103 | $39K |
| Sacubitril/Valsartan | 56 | $36K |
| Sitagliptin Phos/Metformin Hcl | 33 | $18K |
| Fluticasone Propion/Salmeterol | 51 | $13K |
| Insulin Aspart Prot/Insuln Asp | 31 | $12K |
| Levothyroxine Sodium | 438 | $12K |
| Budesonide/Formoterol Fumarate | 24 | $10K |
| Bimatoprost | 39 | $9,525 |
| Losartan Potassium | 627 | $9,503 |
| Ticagrelor | 18 | $9,135 |
| Atorvastatin Calcium | 856 | $8,659 |
Prescribing Profile
Patient Profile
76
Avg Age
59%
Female
1.86
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data